References
- China, N.B.o.S.o. Communiqué of the Seventh National Population Census (No. 2). 2021. Available from: http://www.stats.gov.cn/english/PressRelease/202105/t20210510_1817187.html
- Li J, Li LSW. Development of rehabilitation in China. Phys Med Rehabil Clin N Am. 2019;30(4):769–773. doi: 10.1016/j.pmr.2019.07.010.
- Li JN, Chen S, Zhai L, et al. The advances in hearing rehabilitation and cochlear implants in China. Ear Hear. 2017;38(6):647–652. doi: 10.1097/AUD.0000000000000441.
- Zeng F-G. Celebrating the one millionth cochlear implant. JASA Express Lett. 2022;2(7):077201. doi: 10.1121/10.0012825.
- Rebscher S, Zhou DD, Zeng FG. Development and clinical introduction of the Nurotron cochlear implant electrode array. J Int Adv Otol. 2018;14(3):392–400. doi: 10.5152/iao.2018.6285.
- Gao N, Xu XD, Chi FL, et al. Objective and subjective evaluations of the Nurotron Venus cochlear implant system via animal experiments and clinical trials. Acta Otolaryngol. 2016;136(1):68–77. doi: 10.3109/00016489.2015.1086022.
- Li J, Ji F, Chen W, et al. Analysis of the performance of post-lingually deafened patients with Nurotron((R)) Venus cochlear implants. Acta Otolaryngol. 2014;134(6):609–614. doi: 10.3109/00016489.2014.894250.
- Liu M, Ou Yang YY, Chen XH, et al. Study of auditory rehabilitation performance of postlingual cochlear implantees with Nurotron cochlear. China Med Dev Inf. 2016;22(03):15–17+34. doi: 10.15971/j.cnki.cmdi.2016.03.003.
- Ji F, Xi X. The development of mandarin-Chinese phonetically balanced monosyllable words test list. J Otol. 2007;5:417–426.
- Ji F, Chen AT, Zhao Y, et al. Development of a script of phonemically balanced monosyllable lists of Mandarin-Chinese. J Oto. 2010;5:8–19. doi: 10.13489/j.cnki.11-4883/r.2010.01.003.
- Zhou H, Chen Z, Shi H, et al. Categories of auditory performance and speech intelligibility ratings of early-implanted children without speech training. PLoS One. 2013;8(1):e53852. doi: 10.1371/journal.pone.0053852.
- Yang T, Guo L, Wang L, et al. Diagnosis, intervention, and prevention of genetic hearing loss. Adv Exp Med Biol. 2019;1130:73–92. doi: 10.1007/978-981-13-6123-4_5.
- Zeng FG, Rebscher SJ, Fu QJ, et al. Development and evaluation of the Nurotron 26-electrode cochlear implant system. Hear Res. 2015;322:188–199. doi: 10.1016/j.heares.2014.09.013.
- Naples JG, Ruckenstein MJ. Cochlear implant. Otolaryngol Clin North Am. 2020;53(1):87–102. doi: 10.1016/j.otc.2019.09.004.
- Dhanasingh A, Jolly C. An overview of cochlear implant electrode array designs. Hear Res. 2017;356:93–103. doi: 10.1016/j.heares.2017.10.005.
- Canfarotta MW, Dillon MT, Buchman CA, et al. Long-term influence of electrode array length on speech recognition in cochlear implant users. Laryngoscope. 2021;131(4):892–897. doi: 10.1002/lary.28949.
- Balkany T, Hodges A, Menapace C, et al. Nucleus Freedom North American clinical trial. Otolaryngol Head Neck Surg. 2007;136(5):757–762. doi: 10.1016/j.otohns.2007.01.006.
- Chen J, Chen B, Shi Y, et al. A retrospective review of cochlear implant revision surgery: a 24-year experience in China. Eur Arch Otorhinolaryngol. 2022;279(3):1211–1220. doi: 10.1007/s00405-021-06745-1.
- Layfield E, Hwa TP, Naples J, et al. Failure and revision surgery after cochlear implantation in the adult population: a 10-year single-institution retrospective and systematic review of the literature. Otol Neurotol. 2021;42(3):408–413. doi: 10.1097/MAO.0000000000002940.